Cresco Labs (CRLBF) Change in Accured Expenses (2023 - 2026)

Cresco Labs has reported Change in Accured Expenses for 4 years, with the latest figure at -$7.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 154.76% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$12.9 million (down 430.3% YoY), and the FY2025 full-year result was $8.6 million, up 150.94% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$7.6 million, down from $10.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $20.1 million in Q1 2023, with the low at -$20.5 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged $913230.8 across 4 years, with a median of -$5.2 million in 2024.
• Annual changes were most pronounced in 2025 — Change in Accured Expenses soared 301.51% — and 2026, when it tumbled 154.76%.
• Cresco Labs' Change in Accured Expenses stood at -$11.5 million in 2023, then tumbled by 77.9% to -$20.5 million in 2024, then jumped by 151.87% to $10.6 million in 2025, then slumped by 171.8% to -$7.6 million in 2026.
• The last three Change in Accured Expenses figures came in at -$7.6 million (Q1 2026), $10.6 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.